AbbVie Investigator-Initiated Studies (IIS) Program
- Organization:
- AbbVie
- Category:
- Projectes de recerca
- Scope:
- International
- Start:
- Internal deadline:
- Official deadline:
- Amount:
- Discretionary
- Description:
- 
                                Summary of the Call: 
 AbbVie is committed to supporting investigator-initiated research that advances medical and scientific knowledge related to AbbVie products and therapeutic areas of interest.The AbbVie IIS Program allows academic and community-based physicians and researchers worldwide to apply for support to conduct their own investigator-sponsored studies. Proposals may receive financial and/or product support, subject to the execution of an agreement. Applications begin with a brief study summary submitted through the IIS Study Submission Portal. If shortlisted, applicants may be asked to provide a full protocol and a final study budget for further review. All proposals are evaluated based on scientific merit, alignment with AbbVie's research priorities, and available funding. Therapeutic Areas of Interest (2025 Strategic Priorities): - 
	Aesthetics 
- 
	Eye Care 
- 
	Immunology 
- 
	Neuroscience 
- 
	Oncology 
- 
	Specialty 
 
- 
	
- Requirements
- 
                                Applicant Requirements: 
 The call is open to qualified external investigators from academic or clinical institutions (e.g., universities, hospitals, or research centers). Applicants must be capable of designing and conducting scientific research, comply with institutional and regulatory requirements, and adhere to all relevant laws, regulations, and ethical standards.
- Request
- 
                                In case of interest, please click on 'm'interessa' and we will contact you. 
